NuPotential
Baton Rouge · Founded 2004
About NuPotential
NuPotential produces dedifferentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfer. Its cells are used in therapies that reverse the debilitating effects of diabetes, stroke, heart disease, Alzheimer's disease, Parkinson's disease, and other afflictions, as well as in drug discovery tool applications.
Company Facts
- Founded: 2004
- Legal name: NuPotential, Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $725.0K
- Last round: Series Unknown (Mar 2014)
- Website: nupotential.com
- Phone: +1 225 615 8954
Canonical: https://fsome.com/organization/nupotential-8421545 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.